Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 2,488,000 | 2,397,000 | 2,366,000 | 2,288,000 | 2,295,000 |
Cost of Goods | 1,677,000 | 1,593,000 | 1,595,000 | 1,552,000 | 1,541,000 |
Gross Profit | 811,000 | 804,000 | 771,000 | 736,000 | 754,000 |
Operating Expenses | 481,000 | 449,000 | 471,000 | 469,000 | 412,000 |
Operating Income | 330,000 | 355,000 | 300,000 | 267,000 | 342,000 |
Interest Expense | 49,000 | 44,000 | 43,000 | 40,000 | 40,000 |
Other Income | 21,000 | 3,000 | 17,000 | 18,000 | 3,000 |
Pre-tax Income | 302,000 | 314,000 | 274,000 | 245,000 | 305,000 |
Income Tax | 65,000 | 74,000 | 66,000 | 40,000 | 68,000 |
Net Income Continuous | 237,000 | 240,000 | 208,000 | 205,000 | 237,000 |
Minority Interests | 11,000 | 11,000 | 14,000 | 13,000 | 12,000 |
Net Income | $226,000 | $229,000 | $194,000 | $192,000 | $225,000 |
EPS Basic Total Ops | 2.01 | 2.05 | 1.74 | 1.72 | 1.99 |
EPS Basic Continuous Ops | 2.12 | 2.16 | 1.87 | 1.83 | 2.12 |
EPS Diluted Total Ops | 1.99 | 2.03 | 1.72 | 1.70 | 1.96 |
EPS Diluted Continuous Ops | 2.10 | 2.14 | 1.86 | 1.85 | 2.08 |
EPS Diluted Before Non-Recurring Items | 2.30 | 2.35 | 2.04 | 2.15 | 2.22 |
EBITDA(a) | $455,000 | $472,000 | $416,000 | $376,000 | $453,000 |